Evidence map›Paper›PMID 34802227›Full record

ArticleACS biomaterials science & engineering2021

Nanocomposite Conductive Bioinks Based on Low-Concentration GelMA and MXene Nanosheets/Gold Nanoparticles Providing Enhanced Printability of Functional Skeletal Muscle Tissues.

Selwa Boularaoui, Aya Shanti, Michele Lanotte, Shaohong Luo, Sarah Bawazir, Sungmun Lee, Nicolas Christoforou, Kamran A Khan, Cesare Stefanini

Abstract read
In one paragraph

Article in ACS biomaterials science & engineering, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. MXene Bioinks for 3D Bioprinting: Design and Translation.Small (Weinheim an der Bergstrasse, Germany) · 2026
    Review
  4. Review
  5. Review
  6. Article
  7. Beyond graphene: the MXene era in bioprinting.Biomedical engineering online · 2026
    Review
  8. Graphene and TiACS applied bio materials · 2026
    Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Selwa BoularaouiDepartment of Biomedical Engineering, Khalifa University of Science and Technology, 127788, Abu Dhabi, UAE.ORCID 0000-0002-4333-8584
Aya ShantiDepartment of Biomedical Engineering, Khalifa University of Science and Technology, 127788, Abu Dhabi, UAE.ORCID 0000-0001-9458-8316
Michele LanotteDepartment of Civil Infrastructure and Environmental Engineering, Khalifa University of Science and Technology, 127788, Abu Dhabi, UAE.ORCID 0000-0003-3981-9876
Shaohong LuoDepartment of Biomedical Engineering, Khalifa University of Science and Technology, 127788, Abu Dhabi, UAE.
Sarah BawazirDepartment of Biomedical Engineering, Khalifa University of Science and Technology, 127788, Abu Dhabi, UAE.
Sungmun LeeDepartment of Biomedical Engineering, Khalifa University of Science and Technology, 127788, Abu Dhabi, UAE.ORCID 0000-0002-1699-8376
Nicolas ChristoforouRare Disease Research Unit, Pfizer Inc., 610 Main Street, Cambridge, Massachusetts 02139, United States.ORCID 0000-0003-4594-6919
Kamran A KhanAdvanced Digital and Additive Manufacturing (ADAM) Center, Khalifa University of Science and Technology, 127788, Abu Dhabi, UAE.ORCID 0000-0003-1817-6947
Cesare StefaniniDepartment of Biomedical Engineering, Khalifa University of Science and Technology, 127788, Abu Dhabi, UAE.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is a growing need to develop novel well-characterized biological inks (bioinks) that are customizable for three-dimensional (3D) bioprinting of specific tissue types. Gelatin methacryloyl (GelMA) is one such candidate bioink due to its biocompatibility and tunable mechanical properties. Currently, only low-concentration GelMA hydrogels (≤5% w/v) are suitable as cell-laden bioinks, allowing high cell viability, elongation, and migration. Yet, they offer poor printability. Herein, we optimize GelMA bioinks in terms of concentration and cross-linking time for improved skeletal muscle C2C12 cell spreading in 3D, and we augment these by adding gold nanoparticles (AuNPs) or a two-dimensional (2D) transition metal carbide (MXene nanosheets) for enhanced printability and biological properties. AuNP and MXene addition endowed GelMA with increased conductivity (up to 0.8 ± 0.07 and 0.9 ± 0.12 S/m, respectively, compared to 0.3 ± 0.06 S/m for pure GelMA). Furthermore, it resulted in an improvement of rheological properties and printability, specifically at 10 °C. Improvements in electrical and rheological properties led to enhanced differentiation of encapsulated myoblasts and allowed for printing highly viable (97%) stable constructs. Taken together, these results constitute a significant step toward fabrication of 3D conductive tissue constructs with physiological relevance.

Indexed as

Metal NanoparticlesNanocompositesGelatinGoldMethacrylatesMuscle, SkeletalTissue EngineeringTissue ScaffoldsGelatingelatin methacryloylGoldMethacrylates3D bioprintingGelMAgold nanoparticlesMXene nanosheetsskeletal tissue

Identifiers

PMID34802227
PMCPMC8672345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.